Alterity Therapeutics (ATHE) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Alterity Therapeutics Limited has announced the cessation of over 1.9 billion unquoted options due to their expiry on August 31, 2024, without any exercise or conversion. Following this cessation, the company’s issued capital comprises various classes of equity securities and options, with ordinary fully paid shares totaling over 5.3 billion. This change in the company’s securities structure could impact its market capitalization and investor interests.
For further insights into ATHE stock, check out TipRanks’ Stock Analysis page.
